At a glance
ClinicalIndex Comparison RecordN/ACompleted· 15 enrolled
Drug / intervention
The ZELTIQ Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
DualSculpting the Abdomen Using CoolSculpting
In Brief
A clinical study evaluating The ZELTIQ System for Body Fat Disorder. Completed, enrolled 15 participants across 1 site.
Detailed Summary
Evaluate the safety and efficacy of abdominal DualSculpting with CoolAdvantage applicators.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBody Fat Disorder
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
Enrollment StartOct 2016
First PostedOct 2016
Primary CompletionMar 2017
TodayJul 2026
First PostedOct 21, 2016
Enrollment StartOct 1, 2016
Primary CompletionMar 29, 2017
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 9.7 years ago
Interventions
The ZELTIQ Systemdevice
The CoolSculpting System will be used to perform the treatments with the CoolAdvantage family of applicators.